Skip to main content
. Author manuscript; available in PMC: 2009 Jan 5.
Published in final edited form as: Biol Psychiatry. 2008 Apr 2;64(1):62–69. doi: 10.1016/j.biopsych.2008.02.015

Table 1.

Sample Characteristics and Neuropsychological Performance

Healthy
Participants
(N = 26)
Participants with
Schizophrenia
(N = 40)
p-value
Age 48.26 (9.93) 45.8 (10.21) .40
Age at illness onset ---- 22.75 (7.26) ----
Participant Education 14.26 (1.97) 12.25 (1.96) < .001
Paternal Education 12.64 (4.38) 12.47 (4.34) .90
Gender (M:F) * 18:8 31:9 .45
Race * .67
African American 9 11
Caucasian 17 27
Other 0 2
Antipsychotic Medication
Atypical ---- 29 ----
Typical ---- 6 ----
Typical + Atypical ---- 5 ----
Clinical Ratings
BPRS ---- 36.83 (8.46) ----
SANS ---- 25.94 (14.11) ----
Neurocognitive Test Results
Spatial Span 10.81 (3.06) 7.95 (3.23) .001
Letter-Number Sequencing 16.22 (3.83) 11.70 (3.22) < .001
Hopkins Verbal Learning Test 28.36 (4.08) 20.84 (5.19) < .001
Wechsler Test of Adult Reading 106.78 (15.52) 95.27 (16.35) .005

Note: Table includes means and standard deviations. Except where noted, group differences tested with T-tests. BPRS, Brief Psychiatric Rating Scale; SANS, Scales for the Assessment of Negative Symptoms.

*

Comparison tested with chi-square